Diarrhea is the second leading cause of death for children globally, causing 760,000 deaths each year in children under the age of 5. Amoebic dysentery contributes significantly to this burden, especially in developing countries. We hypothesize that genetic variation contributes to susceptibility to diarrhea-associated Entamoeba histolytica infection in Bangladeshi infants; thus, we conducted a genome-wide association study (GWAS) in two independent birth cohorts of diarrhea-associated E. histolytica infection. Cases were defined as children with at least one diarrheal episode positive for E. histolytica through either PCR or ELISA within the first year of life. Controls were children without any episodes positive for E. histolytica in the same time frame. Meta-analyses under a fixed-effects inverse variance weighting model identified variants in two neighboring genes on chromosome 10: CUL2 (cullin 2) and CREM (cAMP responsive element modulator) associated with E. histolytica infection, with SNP rs58000832 achieving genome-wide significance (Pmeta=4.2x10 -10 ). Each additional risk allele (an intergenic insertion between CREM and CCNY) of rs58000832 conferred 2.5 increased odds of a diarrhea-associated E. histolytica infection. The most associated SNP within a gene was in an intron of CREM (rs58468685, Pmeta=2.3x10 -9 ), which with CUL2, has been implicated as a susceptibility locus for Inflammatory Bowel Disease (IBD) and Crohn's Disease. Gene expression resources suggest these loci are related to the higher expression of CREM, but not CUL2. Increased CREM expression is also observed in early E. histolytica infection. Further, CREM -/mice were more susceptible to E. histolytica amebic colitis. These genetic associations reinforce the pathological similarities observed in gut inflammation between E. histolytica infection and IBD.
Introduction
Despite drastic reductions in childhood mortality from 1990 to 2015, the Millennium Development Goal 4 failed to reach the target goal of 2/3rd reduction in under-5 mortality rate. 1 . One of the leading causes of childhood mortality is diarrheal disease, leading to over half a million deaths annually. 2 The burden of diarrhea-related mortality and morbidity are disproportionately higher in developing countries. One endemic etiology of diarrheal disease in the developing world is amebiasis, an infection by the protozoan parasite Entamoeba histolytica. 3 Observational studies have shown that preschool age children with a history of E. histolytica-associated diarrheal illness were more likely to be malnourished and stunted. 4, 5 While the majority of infections by E. histolytica are asymptomatic 6 , the 10% that develop disease can exhibit acute diarrhea, dysentery, amoebic colitis and amoebic liver abscess. 7 A major risk factor for amebiasis include poor sanitation and hygiene, as transmission occurs via the ingestion of amoebic cysts that are found in contaminated food and water. 8 Within a group of 147 infants followed for the first year of life in an urban slum of Dhaka, Bangladesh, 10.9% of children had at least one diarrheal episode positive for E. histolytica. 9 Children were more likely to be infected with E. histolytica if they were born malnourished. These findings are consistent with prior evidence in preschool age children, which showed children with E. histolytica-associated diarrheal illness were more likely to be malnourished and stunted. 5 By the end of three years of follow-up (from ages 2 to 5), 17% of children had at least one diarrheal episode positive for E. histolytica. Within a homogenous environment with presumed uniform exposure to the pathogen, it is not well understood why only a subset of individuals exposed exhibit infection, and subsequently why symptomatic disease develops only in a subset of those individuals. One possible explanation for the observed heterogeneity in infection rates could be differences in host genetic susceptibility to infection and disease. 10 In a study of preschool age children in Dhaka, Bangladesh, Duggal et al identified a polymorphism in the leptin receptor, rs1137101 resulting in Q223R, was associated with amebiasis when compared to children without this polymorphism. 11 Later work elucidated the mechanism of action of this allele; glutamine at this position led to a decrease in STAT-3-dependent gene expression, which in turn led to an increase in host cell apoptosis during E. histolytica infection. 12, 13 An additional association was found between human leukocyte antigen (HLA) class II alleles and E. histolytica infection in Bangladeshi children, specifically DQB1*0601 and the haplotype containing the DQB1*0601/DRB1*1501 heterozygote. 14 
To comprehensively identify loci conferring risk for diarrhea-associated

Results
Outcome information
Within the well-characterized DBC and PROVIDE studies, children were followed twice weekly for a possible diarrheal episode. When a mother reported diarrhea in her child, a fecal sample was tested for amebiasis. Within DBC, 374 children were reported to have diarrhea; 65 of these children had at least one diarrheal episode positive for E. histolytica within the first year of life. A total of 309 controls had a stool sample collected within the first year of life (diarrheal or normal monthly) and they were not positive for E. histolytica. Within the PROVIDE study, 112 children had at least one diarrheal episode positive for E. histolytica, while 323 did not have any E. histolytica positive samples within the first year of life. (Table 1 ) Diarrhea-associated E. histolytica infection had no association (P > 0.05) with height-for-age Z-score (HAZ) at one year of age, the number of days that the child was exclusively breastfed, or sex. (Table 2 ) Results were consistent between the DBC and PROVIDE (Phet > 0.05).
GWAS meta-analysis identifies significant association in CREM-CUL2 region
A total of 9.8 million SNPs with a pooled (across DBC and PROVIDE) minor allele frequency (MAF) greater than 1% were analyzed for association with diarrhea-associated Entamoeba histolytica infection within the first year of life. A genome-wide association analysis was performed separately for each study (DBC and PROVIDE) using an unadjusted logistic regression assuming an additive model, followed by a fixed effects meta-analysis. (Figure 1 ) The top genetic association (rs58000832, Pmeta=4.2x10 -10 , MAF=23%) was identified on chromosome 10 in a region covering three genes: CUL2 (cullin 2), CREM (cAMP responsive element modulator), and CCNY (cyclin Y) ( Figure 2) . Individuals with at least one copy of the CA insertion at rs58000832, an intergenic insertion between CREM and CCNY, had 2.5 times increased odds of diarrhea-associated infection within the first year of life when compared to individuals with no copies of this insertion. The most associated SNP located in a gene (rs58468685, Pmeta=2.3x10 -9 ) was in an intron of CREM. Within this region of association, there was a large linkage disequilibrium block underlies CREM and CUL2, flanked by two recombination peaks. Haplotype A, the most associated haplotype across both CREM and CUL2, was examined in 5 main continental groups: Africa, the Americas, East Asia, South Asia, and Europe from the 1000 Genomes Project. 16 Using the same SNPs, there were 23 distinct haplotypes seen at least 10 times within the 2,432 unrelated individuals. The risk haplotype from the PROVIDE analysis was found at the highest frequency in South Asian (6.1%) and European (4.4%) populations. East Asian (2.6%) and African (3.8%) populations had lower frequencies of the risk haplotype. A closely related haplotype (only one nucleotide difference from the risk haplotype) was also enriched within South Asian and European populations (12.8% and 12.1%, respectively), with lower frequencies (<5%) in both East Asian and African populations. (Supplementary Table 2 ) These haplotype results suggest that the risk haplotype is enriched within South Asian and European populations. However, there was no evidence supporting either directional or balancing selection. ( Supplementary Figures 1-2) 
(Figure 2)
CREM/CUL2 haplotypes enriched for South Asian populations
eQTL analysis reveals a role for CREM
Within the associated region of CUL2-CREM-CCNY were known cis-eQTLs (expression quantitative trait loci) identified by the Genotype-Tissue Expression (GTEx) Consortium. 17 While known eQTLs in this region included representation of all three genes (CREM, CUL2, CCNY), the only sites that overlapped with our genetic associations from meta-analysis were with CREM. (Figure   2 ) Of the 490 cis-eQTLs for CREM in this region, 167 were significantly associated within the metaanalysis (P<5x10 -7 ). In contrast, none of the CUL2 (n=2) or CCNY (n=80) eQTLs that overlapped with an associated GWAS SNP (P<0.001) reached significance. This suggests that the GWAS associated SNPs may be related to CREM expression, and not CUL2 expression The majority of CUL2 eQTLs were within CCNY and, therefore, outside the area of the association. All CREM eQTLs were in a single cell type: EBV-transformed lymphocytes. Of the SNPs with overlap between the GWAS and GTEx eQTLs, the strongest effect was at rs12248333 (intronic within CUL2). The minor allele (G) has MAF=0.35, and the presence of each allele is was associated with increased odds of diarrheaassociated E. histolytica (P=8.8x10 -8 ) and decreased expression of CREM (P=3.8x10 -6 ). This inverse relationship was consistent for all overlapping eQTLs.
E. histolytica activates cAMP signal transduction and induction of CRE-driven promoter elements via CREM
Previous work has shown that amebic lysates induce significant cAMP elevation in rat colonic mucosa 18 and that secretory products of the parasite increase cAMP in leukocytes 19 . We 
Expression of CREM during amebiasis
To elucidate how CREM impacts susceptibly in vivo we compared CREM expression in wildtype mice that are naturally resistant to E. histolytica and mice with increased susceptibility due to a single amino acid substitution (Q223R) in the leptin receptor. Mice were sacrificed at 12 and 72 hours post-infection. 50% (4/8) of wildtype mice were infected 12 hours post infection and none were infected 72 hours post infection (0/5 infected); in contrast, 77% (10/13) of the susceptible Q223R mice were infected 12 hours post-infection and 35% (6/17) remained infected 72 hours post-infection. 12 CREM expression was increased in both susceptible and wildtype resistant mice 12 hours postinfection regardless of parasite clearance. After 72 hours, CREM expression was significantly lower in mice that had cleared the infection (both wildtype and susceptible) relative to mice that were still infected (Q223R only) (-0.18 +/-0.08, P=0.031) ( Figure 3C ).
CREM knockout mice more susceptible to amebic colitis
To further determine the role of CREM in vivo, we compared the rates of amebic colitis between CREM knockout (C57BL/6J CREM −/− ) and wildtype mice infected by intracecal injection of E. histolytica. CREM knockout mice were more susceptible to amebic colitis than wildtype, as assessed by culture of cecal contents (P=0.02). ( Figure 4A ) Apoptotic death of cecal intestinal epithelial cells, as detected by caspase 3 stain, was also higher within the CREM -/mice (P=0.028). (Figures 4B, 4C) 
Discussion
The most important discovery of this work is that genetic variants in the CREM/CUL2 locus are associated with Entamoeba histolytica diarrhea. Many of our most associated SNPs are also reported to be associated with inflammatory bowel disease susceptibility. 20 The CREM/CUL2 region was identified through the first GWAS conducted on an enteric infectious disease. Haplotype analysis and comparison with 1000 Genomes Project data suggest that this particular association is enhanced in South Asian and European populations. Expression quantitative trait loci (eQTL) analyses identified decreased CREM and likely not CUL2 to be associated with amebiasis. Consistent with eQTL data, and Ulcerative Colitis (UC). Five of these loci overlap between our meta-analysis and previous studies (rs11010067, rs34779708, rs12261843, rs12242110, and rs17582416). ( Table 4 ) Among SNPs with risk allele information, the direction of effect for IBD, Crohn's disease, or ulcerative colitis was in same as the direction of effect for amebiasis. The effect sizes were stronger for amebiasis when compared to IBD, with rs11010067 conferring 1.14 times the odds of Crohn's disease within Europeans while conferring 1.88 times the odds of amebiasis within the Bangladeshi cohort, suggesting overlap between IBD and Entamoeba histolytica infection in this region. This relationship is also confirmed in the clinical literature. It has previously been observed that the gross findings of amoebic colitis can resemble those seen in inflammatory bowel disease, in which amebic colitis patients can be mistakenly diagnosed as UC or CD. 7, 21 The acute stage of amebic colitis especially mimics the first attack of colonic Crohn's disease. 22 These results suggest that there may be a shared pathway for pathogenesis of infection for amebiasis and autoimmunity for Crohn's disease that includes CREM.
The genetic relationship between infection and autoimmune disease it not unprecedented, as leprosy and Crohn's disease are known to share similar genes also. 23 The implications of this finding are intriguing especially since the risk allele or haplotype is common in South Asian and European populations.
The relationship between the intestinal autoimmune diseases, E. histolytica-related diarrhea, and CREM may be along the Th17 pathway. A transcriptional repressor isoform of CREM is denoted ICER (inducible cAMP early repressor) and is regulated through a promoter located in one of CREM's introns. Naive ICER/CREM-deficient CD4+ þ T-cells have impaired functionality to differentiate to Th17, however this can be rescued by forced over-expression of ICER specifically. 24 This relationship is consistent with the role of Th17 cells within autoimmune and inflammatory diseases. Specifically, it was found that ICER/CREM-deficient B6.lpr mice are protected from developing autoimmunity. In addition, high levels of Th17 have been found in the gut of subjects with Crohn's disease. 25 Mouse models have also shown that intracecal amebic infection resulted in the up regulation of Th17 cytokine responses, to the detriment of Th1 cytokines. 26 Further work is needed to elucidate this relationship.
There are several limitations to our analysis. We did not replicate the previously identified association with the leptin receptor, likely due to a different case definition from the original discovery analysis. 11 This previous study looked at infections (both symptomatic and asymptomatic) within children through the preschool years, while our analysis only examined diarrhea-associated infections within the first year of life. Additional limitations may be overcome in future work, such as suboptimal power due to the small sample sizes of both studies ad our constraints in evaluating the role of copathogens. However, because the effect estimates are strong (odds ratio of 2.5 for the most associated risk allele), the combined meta-analysis allowed us to elucidate genome-wide significant associations.
In conclusion, through a meta-analysis of two separate birth cohorts, we uncovered genomewide significant associations with diarrhea-associated Entamoeba histolytica infection within 
Methods
Dhaka Birth Cohort study design: The Dhaka Birth Cohort (DBC) was part of a longitudinal birth cohort recruited from the urban slum in the Mirpur Thana in Dhaka, Bangladesh. Children were enrolled within the first week after birth, beginning in January 2008, and followed-up bi-weekly with household visits for the first year of life. Trained field research assistants took anthropometric measurements at the time of enrollment, and every three months thereafter. The Height-for-Age Zscore (HAZ) and the Weight-for-Age Z-score (WAZ) were calculated by comparing the height and weight of the study participants with the World Health Organization (WHO) reference population, standardized for age and sex, using the WHO Anthro software, version 3.0.1. Diarrheal stool samples were collected from the home or the study field clinic every time the mother reported diarrhea. These samples were then transported to the Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) parasitology laboratory, maintaining a cold chain. The presence of E. histolytica was determined using real-time polymerase chain reaction (RT-PCR), as well as enzyme-linked immunosorbent assay (ELISA). Children were defined as a "case" if they had at least one diarrheal sample that was positive for E. histolytica within the first year of life by either method. Children were defined as "controls" if they had no diarrheal samples that were positive for E. histolytica within the first year of life by either method, and also had at least one diarrheal or monthly stool sample tested for a true negative control.
Dhaka Birth Cohort genotyping:
The samples from DBC were genotyped as part of a larger set of 1,573 samples from four Bangladesh study groups. These samples were genotyped in three separate batches at the University of Virginia Center for Public Health Genomics Laboratory. Sample preparation and genotype calling followed standard Illumina protocols. Only the 484 DBC samples genotyped across three batches were used for this analysis: 165 were genotyped in batch 1 (Illumina Human1M-duoV3; 1,199,187 total SNPs/CNV sites); 154 in batch 2 (Illumina HumanOmni1-Quad v1.0: 1,140,419 total SNPs/CNV probes); and 165 in batch 3 (Illumina HumanOmni2.5-4v1: 2,450,000 total SNPs/CNV probes). Samples were dropped from the analysis if: 1) genotyping call rate was < 95%; 2) they were cryptic duplicates with differing phenotype records or were cryptically related up to first degree in the same study group, relationships inferred with KING 27 ; 3) the inferred sex from the genetic X/Y chromosome data did not match study database gender. SNPs were dropped if: 1) per batch call rate was < 95%; 2) per batch p-value for test of Hardy-Weinberg proportions < 1 x 10 -4 (X chr females only); 3) they were identified as CNV probes; 4) SNPs mapped to multiple locations in the genome. We remapped all SNPs to Human Genome Build 37 and merged individual batches of data into a single combined data set with 529,893 common intersecting SNPs in the 3 batches by rsID. The full data set was imputed to the 1000 Genomes Phase 3 reference data 16 with phasing through SHAPEIT 28, 29 and imputation with IMPUTE2 [30] [31] [32] [33] [34] .
PROVIDE study design:
The "Performance of Rotavirus and Oral Polio Vaccines in Developing Countries" (PROVIDE) Study is a randomized controlled clinical trial birth cohort that was designed to evaluate factors that may influence oral vaccine efficacy among children from areas with high poverty, urban overcrowding, and poor sanitation. 15 A total of 700 children and their mothers were followed for the child's first 2 years of life with a 2x2 factorial design looking specifically at the efficacy of 2-dose Rotarix oral rotavirus vaccine and oral polio vaccine (OPV) with an inactivated polio vaccine (IPV) boost. This study was performed with the International Center for Diarrheal Disease Research, Bangladesh (ICDDR,B) with the study population all from the Mirpur area of Dhaka, Bangladesh. Pregnant mothers were recruited from the community by female Bangladeshi field research assistants (FRAs). Participants had fifteen scheduled follow-up clinic visits, with biweekly diarrhea surveillance at their homes by FRAs. The presence of E. histolytica in the diarrheal samples was determined by RT-PCR. Children were defined as a "case" if they had at least one diarrheal sample that was positive for E. histolytica within the first year of life. Children were defined as "controls" if they had at least one diarrheal sample available for testing, but none were positive for E. histolytica.
Haplotype analyses: For all haplotype analyses, only the genotyped original PROVIDE data was used to avoid potential bias resulting from imputation. The region of association on chromosome 10 between 35.25mb and 35.55mb was subset from the previously phased data, including both CREM and CUL2. A total of 26 SNPs were included in this one large haplotype block. A chi-squared test was used to compare the distribution of outcome in individuals who had a copy of the index haplotype versus those without any copy of the index haplotype. The top associations were then assessed using logistic regression to estimate effect size on an individual, instead of haplotype. The top associated haplotype was then compared against reference populations within the 1000 Genomes Project (TGP). 16 For each superpopulation (Africa, Americas, East Asia, Europe, and South Asia), the 26 SNPs were subset from previously phased data. There were 23 unique haplotypes found within TGP that occurred at least 10 times (on 10 separate chromosomes). The haplotype network was mapped within R, using an infinite site model of DNA sequences from the pairwise deletion of missing data within the library "pegas". Enrichment for a haplotype at a continental level was assessed using a chisquared test.
Selection analyses:
The 1000 Genomes Project (TGP) data for chromosome 10 was assessed for evidence of selection using four representative populations: Bengalis in Bangladesh, Western Europeans in the United States, Han Chinese in Beijing China, and Yoruba in Nigeria. These four populations were selected to be representative of the different continents, as well as the source population for both DBC and PROVIDE. To determine the presence of positive selection, the integrated haplotype score (iHS) was calculated using selscan. [38] [39] [40] [41] [42] To assess the presence of balancing or directional selection, Tajima's D was calculated within vcftools. 43 E. histolytica culture: E. histolytica trophozoites were maintained in a trypsin-yeast extract-iron (TYI-S-33) medium supplemented with 2% Diamond vitamins, 13% heat inactivated bovine serum (Gemini Labs) and 100 U/ml penicillin plus 100 μg/ml streptomycin (Invitrogen). 44 Trophozoites originally derived from HM1: IMSS (ATCC) and passed sequentially through mice to maintain animal virulence were used for challenge experiments.
CRE-Luciferase reporter assays:
HCT116 cells were maintained in McCoy's media supplemented with 10% heat-inactivated fetal bovine serum. Cells were transfected with pCRE Tluc16-DD Vector (Thermo Fisher Scientific (88247) using lipofectamine 2000 (Thermo Fisher Scientific 11668019). The pCRE Tluc16-DD vector contains an optimized minimal core promoter and 5 tandem repeats of the cAMP response element (CRE) a turboluciferase reporter with a dual-destabilization domain. Luciferase levels were measured using the TurboLuc™ Luciferase One-Step Glow Assay Kit (Thermo 88263). Timecourse assays were done with cells exposed to E. histolytica at a ratio of 1 parasite to 5 host cells in transwells to delay contact-dependent cytotoxicity. CREM luciferase assays were done in cells co-transfected with was esiRNA EHU125161 targeting the 2nd DNA binding domain CREM (Sigma) or GFP as a control. E. histolytica secreted products were obtained as previously described. 45 % induction was calculated (mean of biological replicates from experimental condition/mean of biological replicates of the media control) * 100. Error bars representing standard error are shown. P-values were calculated by unpaired t-test with no correction for multiple comparisons using Prism 6.0 (Graphpad).
Q223R mice:
All microarray data discussed in this paper were deposited into NCBI's Gene Expression Omnibus 46 and are accessible through GEO Series accession number GSE43372 (Mackey-lawerence et al). P-values were calculated by unpaired t-test with no correction for multiple comparisons using Prism 6.0 (Graphpad).
Challenge experiments using ICER/ CREM -/mice: C57BL/6J.CREM −/− mice were derived from SV129/Bl6.CREM −/− mice in which the CREM DNA binding domains were replaced by a LacZ-neo fusion cassette, as originally cloned by Blendy et al. 47 These mice were crossed to C57BL/6J mice for over nine generations (Yoshida, et.al. 2016) . All experiments were done strictly according to the IACUC, University of Virginia guidelines and using approved protocol. Infection with E. histolytica was performed on C57BL/6J.ICER/CREM −/− mice and littermate wild type controls. Both male and female mice, between 7-18 weeks of age were used. Mice were regenotyped to validate. Since male mice homozygous for CREM −/− are sterile, we maintained a heterozygous breeding colony. Trophozoites originally derived from HM1:IMSS (ATCC) and passed sequentially through mice to maintain animal virulence were used for infection. Mice received a cocktail of four antibiotics (1g/L each ampicillin, neomycin and metronidazole; 0.5g/L vancomycin) in drinking water for two weeks prior to infection.
Metronidazole was omitted from the cocktail four days prior to challenge. Mice were challenged intracecally with two million trophozoites in 150 μl medium following laparotomy. 48 Mice were euthanized based on their clinical score or on day-3 post challenge, whichever came first. Cecal contents were suspended in 1 ml PBS and 300 μl used for culturing in TYI-S-33 broth for up to five days. Infection rates were analyzed using Chi-square test. 
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